Literature DB >> 11544528

Role of thrombin signalling in platelets in haemostasis and thrombosis.

G R Sambrano1, E J Weiss, Y W Zheng, W Huang, S R Coughlin.   

Abstract

Platelets are critical in haemostasis and in arterial thrombosis, which causes heart attacks and other events triggered by abnormal clotting. The coagulation protease thrombin is a potent activator of platelets ex vivo. However, because thrombin also mediates fibrin deposition and because multiple agonists can trigger platelet activation, the relative importance of platelet activation by thrombin in haemostasis and thrombosis is unknown. Thrombin triggers cellular responses at least in part through protease-activated receptors (PARs). Mouse platelets express PAR3 and PAR4 (ref. 9). Here we show that platelets from PAR4-deficient mice failed to change shape, mobilize calcium, secrete ATP or aggregate in response to thrombin. This result demonstrates that PAR signalling is necessary for mouse platelet activation by thrombin and supports the model that mouse PAR3 (mPAR3) does not by itself mediate transmembrane signalling but instead acts as a cofactor for thrombin cleavage and activation of mPAR4 (ref. 10). Importantly, PAR4-deficient mice had markedly prolonged bleeding times and were protected in a model of arteriolar thrombosis. Thus platelet activation by thrombin is necessary for normal haemostasis and may be an important target in the treatment of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544528     DOI: 10.1038/35092573

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  142 in total

1.  Factor VII deficiency impairs cutaneous wound healing in mice.

Authors:  Zhi Xu; Haifeng Xu; Victoria A Ploplis; Francis J Castellino
Journal:  Mol Med       Date:  2010-02-11       Impact factor: 6.354

2.  Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond.

Authors:  Teresa A Doggett; Gaurav Girdhar; Avril Lawshé; David W Schmidtke; Ian J Laurenzi; Scott L Diamond; Thomas G Diacovo
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

3.  Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling.

Authors:  Koji Eto; Ronan Murphy; Steve W Kerrigan; Alessandra Bertoni; Heidi Stuhlmann; Toru Nakano; Andrew D Leavitt; Sanford J Shattil
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-18       Impact factor: 11.205

Review 4.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

5.  Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.

Authors:  Prafull S Gandhi; Zhiwei Chen; Enrico Di Cera
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

6.  A G(i) -independent mechanism mediating Akt phosphorylation in platelets.

Authors:  B Xiang; G Zhang; J Liu; A J Morris; S S Smyth; T K Gartner; Z Li
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

Review 7.  Signaling during platelet adhesion and activation.

Authors:  Zhenyu Li; M Keegan Delaney; Kelly A O'Brien; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

8.  Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation.

Authors:  Alyssa J Moroi; Nicole M Zwifelhofer; Matthew J Riese; Debra K Newman; Peter J Newman
Journal:  Blood Adv       Date:  2019-04-09

9.  Neutrophils and the kallikrein-kinin system in proteinase-activated receptor 4-mediated inflammation in rodents.

Authors:  Steeve Houle; Martin D Papez; Mara Ferazzini; Morley D Hollenberg; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

10.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.